Results 171 to 180 of about 8,269 (200)
Some of the next articles are maybe not open access.

NLRP3 Inflammasome Activation and Symptom Burden in KRAS-Mutated CMML Patients Is Reverted by IL-1 Blocking Therapy

Cell Reports Medicine, 2023
Teresa Gonzalez   +2 more
exaly  

Problems in the Classification of CMML—Dysplastic Versus Proliferative Type

Leukemia Research, 1998
Norbert Gattermann   +2 more
exaly  

Risk Assessment in Chronic Myelomonocytic Leukemia (CMML)

Leukemia and Lymphoma, 2004
Norbert Gattermann   +2 more
exaly  

CMML

2011
openaire   +1 more source

The heterogeneity of CMML.

Bone marrow transplantation, 1990
O, Krieger   +6 more
openaire   +1 more source

Moving Towards a Uniform Risk Stratification System in CMML - How Far Are We?

Best Practice and Research in Clinical Haematology, 2020
Eric Padron, Onyee Chan
exaly  

A Phase I Study of Lenalidomide in Patients With Chronic Myelomonocytic Leukemia (CMML) – AGMT_CMML-1

Leukemia and Lymphoma, 2018
Peter Valent   +2 more
exaly  

How to treat patients with CMML?

Leukemia Research, 2013
Ulrich, Germing, Judith, Neukirchen
openaire   +2 more sources

Home - About - Disclaimer - Privacy